Skip to main content
. 2014 Oct 7;65(1):28–33. doi: 10.1007/s13224-014-0612-6

Table 4.

Adverse effects

Palonosetron (n = 55) Ramosetron (n = 54)
0–2 h after spinal anesthesia
 Headache 8 (14.5 %) 7 (12.9 %)
 Dizziness 5 (9.1 %) 3 (5.5 %)
 Constipation 0 0
 Myalgia 1 (1.8 %) 1 (1.8 %)
2–24 h after spinal anesthesia
 Headache 7 (12.7 %) 8 (14.8 %)
 Dizziness 3 (5.4 %) 3 (5.5 %)
 Constipation 2 (3.6 %) 2 (3.7 %)
 Myalgia 0 0
24–48 h after spinal anesthesia
 Headache 6 (10.9 %) 5 (9.2 %)
 Dizziness 3 (5.4 %) 3 (5.7 %)
 Constipation 4 (7.2 %) 4 (7.4 %)
 Myalgia 0 0